Diabetes, Metabolic Syndrome and Obesity (Mar 2021)
Factors to Consider When Determining Whether Lipotoxicity Solely Causes B-Cell Decompensation in KPT2D [Letter]
Abstract
Dan Geltser Imperial College London, School of Medicine, London, UKCorrespondence: Dan GeltserImperial College London, School of Medicine, London, UKEmail [email protected] I read with great interest the paper by Ye et al,1 which identified the significance of raised triglycerides in the treatment of ketosis-prone type 2 diabetes (KPT2D). The study concluded the need to implement lifestyle changes and administration of lipid-lowering medication for paediatric, hyperglycaemic KPT2D patients. As a 5th year medical student, who completed an intercalated BSc focusing on lipidology in diabetes mellitus, I would like to discuss further factors which should be considered when evaluating the conclusion. View the original paper by Ye and colleagues
